Sage Therapeutics, Inc. Reports Q3 Loss, Tops Revenue Estimates
| PRRUF Stock | USD 0.20 0.00 0.00% |
Roughly 62% of Immutep's investor base is looking to short. The analysis of overall sentiment of trading Immutep Limited pink sheet suggests that many investors are alarmed at this time. The current market sentiment, together with Immutep's historical and current headlines, can help investors time the market. In addition, many technical investors use Immutep Limited stock news signals to limit their universe of possible portfolio assets.
Immutep pink sheet news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Immutep daily returns and investor perception about the current price of Immutep Limited as well as its diversification or hedging effects on your existing portfolios.
Immutep |
Sage Therapeutics delivered earnings and revenue surprises of -0.66 percent and 7.55, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock
Read at zacks.com
 |
Immutep Fundamental Analysis
We analyze Immutep's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Immutep using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Immutep based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Gross Profit
Gross Profit Comparative Analysis
Immutep is currently under evaluation in gross profit category among its peers. Gross Profit is the most basic measure of business operational efficiency. It is simply the difference between sales revenue and the cost associated with making a product or providing a service. It is calculated before deducting administrative expenses, taxes, and interest payments.
Immutep Limited Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Immutep pink sheet to make a market-neutral strategy. Peer analysis of Immutep could also be used in its relative valuation, which is a method of valuing Immutep by comparing valuation metrics with similar companies.
Peers
Immutep Related Equities
| ENVB | Enveric Biosciences | 9.09 | ||||
| SLN | Silence Therapeutics | 2.33 | ||||
| AADI | Aadi Bioscience | 0.41 | ||||
| CDTX | Cidara Therapeutics | 0.82 | ||||
| CYTK | Cytokinetics | 0.91 | ||||
| CGEM | Cullinan Oncology | 2.56 | ||||
| CTMX | CytomX Therapeutics | 5.08 | ||||
| VRDN | Viridian Therapeutics | 5.22 | ||||
| ALXO | Alx Oncology | 5.96 | ||||
| ELEV | Elevation Oncology | 6.94 | ||||
| GPCR | Structure Therapeutics | 7.42 | ||||
| CRNX | Crinetics Pharmaceuticals | 7.53 | ||||
| APLT | Applied Therapeutics | 8.06 | ||||
| IMMX | Immix Biopharma | 8.19 | ||||
| ALVR | Allovir | 9.80 | ||||
| ZNTL | Zentalis Pharmaceuticals | 10.57 | ||||
| ADCT | ADC Therapeutics | 10.81 | ||||
| DSGN | Design Therapeutics | 11.01 | ||||
| ZURA | Zura Bio | 12.35 | ||||
| SANA | Sana Biotechnology | 12.82 | ||||
| OLMA | Olema Pharmaceuticals | 20.10 |
Complementary Tools for Immutep Pink Sheet analysis
When running Immutep's price analysis, check to measure Immutep's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immutep is operating at the current time. Most of Immutep's value examination focuses on studying past and present price action to predict the probability of Immutep's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Immutep's price. Additionally, you may evaluate how the addition of Immutep to your portfolios can decrease your overall portfolio volatility.
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data |